Guest View
User: Pass: | become a member
Archive for 2012

World Markets Weekend Review: A Mixed Start for 2012

Courtesy of Doug Short.

Note from dshort: At the suggestion of Joerg Willig, a finance professional in Germany, I have replaced the DAX index, which includes dividends, with the price-only DAXK. This change levels the playing field, so to speak, for our international comparisons.


Our eight benchmark world indexes got off to a mixed start for 2012, again on thin volume and variously abbreviated by a mix of market holidays. The DAXK and BSE SENSEX were the stellar performers, a full percent above the S&P 500, which also had strong opening week, as did the FTSE 100. The Shanghai finished last and is now a stunning 37.68% off its interim high. In fact, the adjacent chart shows that six of our eight indexes are more than 20% off their interim highs.

A Closer Look at the Last Four Weeks

The tables below provide a concise overview of performance comparisons over the past four weeks for these eight major indexes. I’ve also included the average for each week so that we can evaluate the performance of a specific index relative to the overall mean and better understand weekly volatility. The colors for each index name help us visualize the comparative performance over time.

The chart below illustrates the comparative performance of World Markets since March 9, 2009. The start date is arbitrary: The S&P 500, CAC 40 and BSE SENSEX hit their lows on March 9th, the Nikkei 225 on March 10th, the DAX on March 6th, the FTSE on March 3rd, the Shanghai Composite on November 4, 2008, and the Hang Seng even earlier on October 27, 2008. However, by aligning on the same day and measuring the percent change, we get a better sense of the relative performance than if we align the lows.

Click to View
Click for a larger image

A Longer Look Back

Here is the same chart starting from the turn of 21st century. The relative over-performance of the emerging markets (Shanghai, Mumbai, Hang Seng) is readily apparent.

Click to View
Click for a larger image

Check back next weekend for a new update.

 

 

 

 





Inhibitex Deal Leaked Or Just ‘Exceptional’ Timing?

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

Early Friday morning, Jon Najarian of optionMONSTER fame noted (on his site as well as CNBC) some ‘unusual’ action in an illiquid little stock called Inhibitex (INHX). It turns out that over the weekend, that same company was purchased by BMY for $2.5bn (or $26 per share – more than double the closing print of $9.87 on January 6th). This won’t be the first time we have ‘helped’ Mary (Schapiro) and her little SEC lambs but it seems surprising that this would not generate at least an ‘alert’ when as Najarian so promptly pointed out on Friday – a total of 11,138 calls traded against only 937 puts with this call volume more than half the entire call trades of the month of December (when 19,000 calls changed hands). Friday’s call activity was more than 12 times average, with the $10 Feb Calls’ volume over 17 standard deviations above normal.

This isn’t the first time sizable call volume (green above versus put volume – red) has been seen but it is the most extreme example of the kind of well-informed trading that we have discussed again and again with regard healthcare specifically.

The largest trade that stuck out was the purchase of 2,000 Feb 10 calls for $2.00. Based on the BMY takeover price, these calls are now worth $16 ($26 minus the $10 call strike). That means the well-informed (lucky) owner turned $200,000 into $3,200,000 over the weekend.

While some of the action could potentially be discounted as front-running the JPMorgan Healthcare conference next week, we leave it to you to judge the option volume for itself: either the deal was leaked or the buyer of these calls had exceptional timing and is now considerably richer.

Charts: Bloomberg





On Trading Central Tendency

Courtesy of ZeroHedge. View original post here.

Submitted by Bruce Krasting.

It’s been about a week since the Federal Reserve announced its new policy of providing information to the public regarding the direction of US interest rates. The new policy is not, generally, a surprise. The Wall Street Journal’s Jon Hilsenrath told us something was coming weeks ago. I've been pondering whether this is a positive or a negative development. I’ve concluded that this step by the Fed will backfire and will  prove to be a mistake.

It’s tough to argue against a policy of more disclosure by the Fed. The members are a secretive bunch to begin with. Most people have a level of distrust of the Fed. More information about what they are doing and why, would be helpful. However, I believe the decision to provide more info has nothing to do with the Fed wanting to be more open and lovable. The Fed has taken this step in an effort to make its current policy decisions more effective.

I think any policy of the Federal Reserve should be designed to stand the test of time. It must be effective in all anticipated future conditions. The move by the Fed may well achieve the desired short-term objectives. Businesses, investors and individuals will have a greater degree of certainty regarding the future direction and timing of changes in interest rates. On balance, the additional information should have mildly positive consequences on new capital investments by companies, the process of capital formation in the markets, and it might allow individuals to make better long-term investment choices. What’s not to like?

The Fed currently publishes information regarding the thinking of the Fed members on both GDP and inflation (the SEP report). I was surprised to see that the revised report will now include a projection for the likely timing of the first rate hike. (This aspect of the Fed's release was not in the WSJ article.)

The 12 Fed governors will provide their estimates of when the first rate hike will occur. The top and bottom three will be excluded. The full range of estimates could, for example be from 2013 to 2016. But the narrow estimate would be more precise. It could be from June 2013 to June of 2014.

In the above example, the “Central Tendency” of the expectation for a change in…
continue reading





Interactive Comparison Of GDP: America vs The World

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

Curious how the US, on a state by state basis, stacks up against the rest of the world, in terms of economic (and population) prowess? The following interactive graphic from the Economist should answer all questions about what state is equivalent to what country. With some surprises: as the Economist points out: “Who would have thought that, despite years of auto-industry hardship, the economy of Michigan is still the same size as Taiwan’s?” On the other hand Montana Grungeville being equal to Greece in GDP – that we could live with…

h/t Peter Eller





Investor Sentiment: Are Investors Rushing Towards the Edge of a Cliff?

Courtesy of ZeroHedge. View original post here.

Submitted by thetechnicaltake.

Last week, I stated that “higher prices should be supported by increasing number of bulls, and this would be a signal that a sustainable rally, that everyone so desperately wants, is unfolding.” So this past week, the SP500 gained about 1.6% and bullishness increased dramatically both in the Rydex data set and with the “dumb money” indicator. Yet, despite these positive developments to recruit more investors into the bullish camp, much work needs to be done. Volume is the probably the biggest issue, and the lack of volume means lack of investor conviction. So while there are more bulls, they are chasing prices higher with one hand already on the eject button. My data still suggests a mixed sentiment picture, and at this stage of the rally (relative to the time elapsed from the October lows), prices and bullish sentiment should have been much greater. The fact that the bulls have yet to take the reigns of this market suggests caution. These are still not the makings of a sustainable rally. This still looks like investors are rushing to the edge of a cliff as opposed to the promise land and nirvana of a bull market.





Vertex Announces Key 2012 Business Objectives as Company Prepares for Planned Global Launch of KALYDECO in Cystic Fibrosis

Courtesy of Benzinga.

Vertex Pharmaceuticals (NASDAQ: VRTX) announced Sunday its 2012 business objectives in conjunction with the 30th Annual J.P. Morgan Healthcare Conference in San Francisco. Matthew Emmens, Chairman, President and Chief Executive Officer of Vertex, and Jeffrey Leiden, M.D., Ph.D., who will become Vertex’s CEO on February 1, 2012, will discuss these objectives as part of a live presentation, which will be available on Vertex’s website, www.vrtx.com, on Monday, January 9 at 11:00 a.m. PT (2:00 p.m. ET).

“In 2011, our team executed a highly successful launch for INCIVEK in hepatitis C, with more than 25,000 people starting treatment since its approval in mid-2011,” said Mr. Emmens. “With the strength of the launch for INCIVEK, the submission of our global approval applications for KALYDECO in cystic fibrosis and the advancement of our pipeline programs, we are positioned for significant growth, earnings and cashflow in 2012.”

In December, Vertex announced that the U.S. Food and Drug Administration accepted the New Drug Application for KALYDECO and granted the company’s request for six-month Priority Review. A target review date of April 18, 2012 is set under the Prescription Drug User Fee Act for the FDA’s approval decision. Vertex’s marketing authorization application for KALYDECO has also been validated by the European Medicines Agency, which accepted Vertex’s request for accelerated assessment in Europe.


For more Benzinga, visit Benzinga Professional Service, Value Investor, and Stocks Under $5.





Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook

Courtesy of Benzinga.

Sequenom (NASDAQ: SQNM) announced Sunday, highlights of the Company’s 2011 performance and accomplishments, as well as preliminary activities and goals for the first part of 2012.

Initial 2011 Performance Results Total revenue growth of approximately 23 percent year-over-year for 2011 (unaudited).

Over 21,000 total prenatal and retinal diagnostic tests were billed during the year.

Sales in the Genetic Analysis business segment were up approximately 6 percent from 2010 (unaudited), each quarter improving over the same period in the prior year.

Positive results following the October 2011 launch of Sequenom Center for Molecular Medicine’s (Sequenom CMM) MaterniT21 laboratory developed test:

The MaterniT21 LDT is now available for sale through Sequenom CMM in all 50 states in the U.S., including New York .

The Company received its first payments as an out-of-network provider from major commercial payors within the first billing cycle post-launch. At the close of the year, a new blood draw tube was introduced for the collection of MaterniT21 samples, allowing for blood to be drawn directly at a doctor’s office and shipped at ambient temperature.

“The accomplishments achieved in 2011, particularly in the last quarter with the launch and positive trajectory of the MaterniT21 LDT, are a reflection of the Company’s dedication to achieving our mission to deliver genetic analysis solutions to improve patient care,” said Harry F. Hixson, Jr , Ph.D., Chairman and CEO of Sequenom. “2011 was a year primarily dedicated to reaching our research and development goals, all of which we met. In 2012, our primary focus will be on effective commercialization with an emphasis on the MaterniT21 LDT.”

Looking forward to 2012, Sequenom CMM will continue to expand commercialization of the MaterniT21 LDT, among its other offerings. The laboratory has established an internal corporate goal of billing a minimum of 25,000 MaterniT21 tests this year, while increasing the sales force head count for the diagnostics business to more than 50 active field sales representatives. In addition, study results determining the accuracy of the MaterniT21 LDT in detecting two additional fetal abnormalities, Trisomy 13 and Trisomy 18, are scheduled to be published in a peer-reviewed journal during the first quarter of this year.


For more Benzinga, visit Benzinga Professional Service, Value Investor, and Stocks Under $5.





2012 – The Year Of Living Dangerously

Courtesy of Jim Quinn of The Burning Platform

2012 – The Year Of Living Dangerously

“In retrospect, the spark might seem as ominous as a financial crash, as ordinary as a national election, or as trivial as a Tea Party. The catalyst will unfold according to a basic Crisis dynamic that underlies all of these scenarios: An initial spark will trigger a chain reaction of unyielding responses and further emergencies. The core elements of these scenarios (debt, civic decay, global disorder) will matter more than the details, which the catalyst will juxtapose and connect in some unknowable way. If foreign societies are also entering a Fourth Turning, this could accelerate the chain reaction. At home and abroad, these events will reflect the tearing of the civic fabric at points of extreme vulnerability –  problem areas where America will have neglected, denied, or delayed needed action.” – Strauss & Howe – The Fourth Turning - 1997

  

In December 2010 I wrote an article called Will 2012 Be as Critical as 1860?, that pondered what might happen with the 2012 presidential election and the possible scenarios that might play out based on that election. Well, 2012 has arrived and every blogger and mainstream media pundit is making their predictions for 2012. The benefit of delaying my predictions until the first week of 2012 is that I’ve been able to read the wise ponderings of Mike Shedlock, Jesse, Karl Denninger, and some other brilliant truth seeking analysts regarding what might happen during 2012. The passage above from Strauss & Howe was written fifteen years ago and captured the essence of what has happened since 2007 and what will drive all the events over the next decade. Predicting specific events is a futile human endeavor. The world is so complex and individual human beings so impulsive and driven by emotion, that the possible number of particular outcomes is almost infinite.

But, as Strauss and Howe point out, the core elements that created this Crisis and the reaction of generational cohorts to the implications of debt, civic decay and global disorder will drive all the events that will occur in 2012 and for as far as the eye can see. Linear thinkers in mega-corporations, mainstream media and Washington D.C. focus on retaining the status quo, their power and their wealth. They believe an economic recovery can be manufactured through…
continue reading





Some ETFs Are Hot, Some Are Not (IAT, ITB, IYH, SLV, EWI)

Courtesy of John Nyaradi.

Some ETFs Are Hot, Some Are Not (IAT, ITB, IYH, SLV, EWI)
Some ETFs are hot and some are not as we enter 2012

A famous stock market axiom says that “a rising tides lifts all boats,” however, in markets like today’s bifurcated environment, vast differences of performance and risk can exist among various sectors and ETFs.

Hot ETFs:

iShares Dow Jones Regional Bank Fund (NYSEARCA:IAT) has gained 7.9% over the last four weeks.  Major holdings include US Bancorp (NYSE:USB) PNC Financial Services (NYSE:PNC) and SunTrust (NYSE:STI)  The banking sector has been bolstered in recent weeks by improving economic reports from the United States and growing sentiment that the European debt crisis might be successfully brought under control.  Also, Federal Reserve support for the endangered housing industry has added strength to the financial sector.  After coming off lows set in December, the index (NYSEARCA:IAT) has vaulted through both its 50 day and 200 day moving averages.

iShares Dow Jones U.S. Home Construction (NYSEARCA:ITB) up 4.6% over the last four weeks. Major holdings include DR Horton, (NYSE:DHI) Lennar (NYSE:LEN) and Toll Brothers (NYSE:TOL) and the ETF seeks to track the Dow Jones U.S. Select Home Construction Index. The sector has experienced recent strength on the hopes for more help for the housing industry and recent improvements in sales, home construction and building permit numbers.  Lennar reports earnings on January 11th and analysts estimate 6% earnings improvement over this time last year.  On a technical basis, the home construction ETF (NYSEARCA:ITB) is above both its 50 and 200 day moving averages and so is in bull market territory.

iShares Dow Jones U.S. Health Care (NYSEARCA: IYH) has gained 4.8% over the last four weeks. Designed to track the U.S. Healthcare Index, (NYSEARCA:IYH) has major holdings in Merck, Pfizer and Johnson and Johnson.  Merck recently reached new highs in its stock and the healthcare sector is generally seen as a defensive play during difficult times when investors are looking for dividends and stable holdings.  The technical picture is also very strong here as the sector comes off its early December lows.

Not Hot ETFs:

On the other end of the spectrum, investors are having less fun with positions in ETFs and sectors that have been suffering as of late.

iShares Silver Trust (NYSEARCA:SLV) has tumbled 12.6% in the last thirty days and is in a bear market configuration from a technical standpoint. Both silver and gold have…
continue reading






 
 
 

Chart School

Joe Friday: This took place in 1987, 2000 and Now

Courtesy of Doug Short.

Advisor Perspectives welcomes guest contributions. The views presented here do not necessarily represent those of Advisor Perspectives.

The lower section of the chart below measures five-year rolling performance of the S&P 500. This great chart comes from Shortsideoflong.com.

In the past 50-years, five-year rallies of 170% or more have only taken place in 1987 and 2000.


 


Click for a larger image ...

more from Chart School

Zero Hedge

Obama Administration Encouraged Insider Trading

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

Back in 2011, many people were outraged when it was revealed that two months before the US Treasury pushed the insolvent GSEs into bankruptcy, then Treasury Secretary, Goldman alum Hank Paulson held a secret meeting with various hedge funds (most of them headed by Goldman alumni themselves) in which he gave them advance warning about the imminent bankruptcy, and allowing them to trade appropriately on material, and certainly non-public information.

Since then the general population has gotten far more used to encouraged criminal activity and facilitated insider tra...



more from Tyler

Insider Scoop

Rovi Announces Sale of MainConcept Businesses

Courtesy of Benzinga.

Related ROVI U.S. Court Of Appeals Sides With Amazon In Rovi Lawsuit Market Wrap For April 8: Markets Bounce Higher As Earnings Season Begins

Rovi Corporation (NASDAQ: ROVI), a global leader in entertainment discovery, announced it has entered into a definitive agreement to sell its DivX and MainConcept businesses. Rovi had previously announced its intent to sell the DivX and MainConcept businesses by the end of the second qua...



http://www.insidercow.com/ more from Insider

Market Shadows

Canary In the Yen Shaft: $10 trillion JGBs; No Bids!

Two guest authors, David Stockman and long-time contributor John Rubino, write about the current state of Abenomics. 

Canary In the Yen Shaft: $10 trillion JGBs; No Bids!

By  

This one matters a lot. Abenomics was predicated on a lunatic notion—namely, that the economic ills from Japan’s massive debt overhang could be cured by a central bank bond buying spree that was designed to be nearly 3X larger relative to its GDP than that of the Fed. Yet anyone with a modicum of common sense and market...



more from Paul

Option Review

Wild Ride For Chipotle

Shares in Chipotle Mexican Grill Inc. (Ticker: CMG) opened higher on Thursday morning, rising more than 6.0% to $589.00, after the restaurant operator reported better than expected first-quarter sales ahead of the opening bell. But, the stock began to falter just before lunchtime on concerns the burrito-maker will increase menu prices for the first time in three years. The price of Chipotle’s shares have since fallen into negative territory and currently trade down 3.5% on the session at $532.89 as of 1:50 p.m. ET.

Chart – Shares in Chipotle cool by lunchtime

...

more from Caitlin

Phil's Favorites

The Best of TRB 2014 - Investing and Psychology

 

The Best of TRB 2014 – Investing and Psychology

Courtesy of 

This week I’m in Disney World with the family, our first proper vacation all together in years. As such, I’m off the grid and away from computers of any kind (I’m trying to stay married, you guys). But while I’m gone, I’ve left you some stuff to catch up on…

These were the biggest posts – as read and shared by you – during the first quarter of this year. The theme of today’s collection is good investing and understanding the psychological forces at work when we commit capital. No matter how long I’m doing this...



more from Ilene

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Sabrient

What the Market Wants: Positive News and Stocks at Bargain Prices

Courtesy of David Brown, Sabrient Systems and Gradient Analytics

Last week’s market performance was nasty again, especially for the Small-cap Growth style/cap, down 4%.  Large-caps faired the best, losing only 2.7%.  That’s ugly and today’s market seemed likely to be uglier today with escalating tensions over the weekend in Ukraine. 

But once again, positive economic trumped the beating of the war drums. Retail Sales jumped up 1.1% over a projected 0.8% and last month’s tepid 0.3%, which was revised up to 0.7%.  While autos led, sales were up solidly overall.  Business inventories were about as expected with a positive tone.  Citigroup (C) handily beat estimates to add to the morning’s surprises.  As a result, the market was positive through most of the day, led by the DJI, up 0.91%, and the S&P 500, up 0.82%.  NASDAQ had a less...



more from Sabrient

Digital Currencies

Facebook Takes Life Seriously and Moves To Create Its Own Virtual Currency, Increases UltraCoin Valuation Significantly

Courtesy of ZeroHedge. View original post here.

Submitted by Reggie Middleton.

The Financial Times reports:

[Facebook] The social network is only weeks away from obtaining regulatory approval in Ireland for a service that would allow its users to store money on Facebook and use it to pay and exchange money with others, according to several people involved in the process. 

The authorisation from Ireland’s central bank to become an “e-money” institution would allow ...



more from Bitcoin

OpTrader

Swing trading portfolio - week of April 14th 2014

Reminder: OpTrader is available to chat with Members, comments are found below each post.

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here...



more from OpTrader

Stock World Weekly

Stock World Weekly

Newsletter writers are available to chat with Members regarding topics presented in SWW, comments are found below each post.

Here is the new Stock World Weekly. Please sign in with your user name and password, or sign up for a free trial to Stock World Weekly. Click here. 

Chart by Paul Price.

...

more from SWW

Promotions

See Live Demo Of This Google-Like Trade Algorithm

I just wanted to be sure you saw this.  There’s a ‘live’ training webinar this Thursday, March 27th at Noon or 9:00 pm ET.

If GOOGLE, the NSA, and Steve Jobs all got together in a room with the task of building a tremendously accurate trading algorithm… it wouldn’t just be any ordinary system… it’d be the greatest trading algorithm in the world.

Well, I hate to break it to you though… they never got around to building it, but my friends at Market Tamer did.

Follow this link to register for their training webinar where they’ll demonstrate the tested and proven Algorithm powered by the same technological principles that have made GOOGLE the #1 search engine on the planet!

And get this…had you done nothing b...



more from Promotions

Pharmboy

Here We Go Again - Pharma & Biotechs 2014

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Ladies and Gentlemen, hobos and tramps,
Cross-eyed mosquitoes, and Bow-legged ants,
I come before you, To stand behind you,
To tell you something, I know nothing about.

And so the circus begins in Union Square, San Francisco for this weeks JP Morgan Healthcare Conference.  Will the momentum from 2013, which carried the S&P Spider Biotech ETF to all time highs, carry on in 2014?  The Biotech ETF beat the S&P by better than 3 points.

As I noted in my previous post, Biotechs Galore - IPOs and More, biotechs were rushing to IPOs so that venture capitalists could unwind their holdings (funds are usually 5-7 years), as well as take advantage of the opportune moment...



more from Pharmboy



FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>